David A. Rodeberg
University of Kentucky(US)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Tumors and Oncological Cases, Bone Tumor Diagnosis and Treatments, Testicular diseases and treatments, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803(2009)363 cited
- → Primary Hyperparathyroidism in Pediatric Patients(2005)254 cited
- → Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group(2015)216 cited
- → Rhabdomyosarcoma(2016)201 cited
- → Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children’s Oncology Group(2018)170 cited
- → Nitric oxide: An overview(1995)155 cited
- → Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group(2019)149 cited
- → Update on rhabdomyosarcoma(2012)135 cited
- CpG oligodeoxynucleotides potentiate the antitumor effects of chemotherapy or tumor resection in an orthotopic murine model of rhabdomyosarcoma.(2003)
- → DOES BLADDER PRESERVATION (AS A SURGICAL PRINCIPLE) LEAD TO RETAINING BLADDER FUNCTION IN BLADDER/PROSTATE RHABDOMYOSARCOMA? RESULTS FROM INTERGROUP RHABDOMYOSARCOMA STUDY IV(2004)133 cited